Gender‐Based Differences and Menstrual Cycle‐Related Changes in Specific Diseases: Implications for Pharmacotherapy

Pharmacotherapy - Tập 20 Số 5 - Trang 523-539 - 2000
Mary H. H. Ensom1
1Faculty of Pharmaceutical#R# Sciences, University of British Columbia, Vancouver, Canada.

Tóm tắt

Pharmacists should be aware of gender‐based differences and menstrual cycle‐related changes in six diseases: asthma, arthritis, migraine, diabetes, depression, and epilepsy. In general, women report symptoms of physical illness at higher rates, visit physicians more frequently, and make greater use of other health care services than men. Whereas reasons for these gender differences are not fully clear, a combination of biologic, physiologic, social, behavioral, psychologic, and cultural factors most likely contributes. A significant percentage of women with asthma, arthritis, migraine, diabetes, depression, or epilepsy experience worsening of their disease premenstrually. The mechanism is unknown, but is speculated to be multifactorial because of many endogenous and exogenous modulators and mediators of each disease. As part of general therapy for cycle‐related exacerbations of any one of these disorders, patients should be encouraged to use a menstrual calendar to track signs and symptoms for two to three cycles; if cyclic trends are identified, the women should anticipate exacerbations and avoid triggering factors. Cyclic modulation with pharmacotherapy may be attempted. If unsuccessful, a trial of medical ovulation suppression with a gonadotropin‐releasing hormone (GnRH) analog may be warranted. If that is successful, continuous therapy with a GnRH analog and steroid add‐back therapy or less expensive alternatives may be effective. If pharmacotherapy is impractical, hysterectomy and bilateral oophorectomy with estrogen replacement therapy is a last resort. Gender differences and menstrual cycle‐related changes are important areas for clinical and mechanistic research.

Từ khóa


Tài liệu tham khảo

10.2307/2136750

Legato MJ, 1997, Gender‐specific physiology: how real is it? how important is it?, Int J Fertil, 42, 19

Legato MJ, 1998, Women's health: not for women only, Int J Fertil, 43, 65

10.1016/0166-2236(86)90158-X

10.1016/0037-7856(75)90094-3

American Medical Association Council on Ethical and Judicial Affairs, 1991, Gender disparities in clinical decision making, JAMA, 266, 559, 10.1001/jama.1991.03470040123034

10.1300/J013v11n02_03

United States Department of Health and Human Services, 1997, Vital and health statistics: prevalence of selected chronic conditions: United States, 1990–92

National Center for Health Statistics 1999 Health and aging chartbook in health United States 1999 list of figures

10.1097/00005650-198711000-00007

10.1023/A:1008627824731

10.1097/00042560-199812010-00005

Sung JC, 1998, Factors affecting patient compliance with antihyperlipidemic medications in an HMO population, Am J Manage Care, 4, 1421

10.1046/j.1525-1497.1998.00180.x

Tardivel J, 1998, Gender differences in relation to motivation and compliance in cardiac rehabilitation, Nurs Crit Care, 3, 214

10.1089/jwh.1998.7.717

10.1097/00007435-199801000-00001

10.1016/S0954-6111(97)90085-8

10.1038/sj.sc.3100367

10.1089/jwh.1997.6.219

Watts RW, 1997, Do patients with asthma fill their prescriptions? A primary compliance study, Aust Fam Physician, 26, S4

10.1093/sleep/20.1.28

10.2105/AJPH.86.12.1805

10.1016/S0149-2918(96)80080-4

10.1902/jop.1996.67.10.976

10.1177/106002809603001003

10.1001/archfami.5.5.297

Geest S, 1995, Incidence, determinants, and consequences of subclinical non‐compliance with immunosuppressive therapy in renal transplant recipients, Transplantation, 59, 340, 10.1097/00007890-199502000-00006

10.1016/S0022-3476(05)80257-4

Centers for Disease Control and Prevention, 1998, Forecasted state‐specific estimates of self‐reported asthma prevalence—United States, 1998, MMWR, 47, 1022

Centers for Disease Control and Prevention, 1992, Asthma—United States, 1980–90, MMWR, 41, 733

Skobeloff EM, 1992, The influence of age and sex on asthma admissions, JAMA, 268, 3437, 10.1001/jama.1992.03490240045034

10.3109/02770909109110626

10.1016/0091-6749(88)90187-X

Gluck JC, 1975, The effects of pregnancy on asthma: a prospective study, Ann Allergy, 37, 164

Schatz M, 1992, Asthma during pregnancy: interrelationships and management, Ann Allergy, 68, 123

McDonald CF, 1996, Asthma in pregnancy and lactation: a position paper for the Thoracic Society of Australia and New Zealand, Med J Aust, 165, 485, 10.5694/j.1326-5377.1996.tb138613.x

10.1164/ajrccm.157.1.9612063

Bonner JR, 1984, The epidemiology and natural history of asthma, Clin Chest Med, 5, 557, 10.1016/S0272-5231(21)00281-1

10.1136/bmj.280.6229.1397

10.1164/ajrccm/151.3_Pt_1.647

National Center for Chronic Disease Prevention and Health Promotion, Arthritis, Chronic disease prevention

Centers for Disease Control and Prevention, 1995, Prevalence and impact of arthritis among women—United States, 1989–1999, MMWR, 44, 329

10.1002/art.1790090603

10.1097/00002281-199002020-00010

10.1002/art.1780330604

Wingrave SJ, 1978, Reduction in incidence of rheumatoid arthritis associated with oral contraceptives, Lancet, 1, 569

10.1016/S0140-6736(83)92413-3

10.1002/art.1780330705

10.1002/art.1780330204

10.1002/art.1780331002

10.1097/00001648-199003000-00012

Carette S, 1989, Postmenopausal hormones and the incidence of rheumatoid arthritis, J Rheumatol, 16, 911

Nelson JL, 1998, Pregnancy, immunology and autoimmune disease, J Reprod Med, 43, 335

10.1002/art.1790090605

10.1016/S0950-3579(05)80344-9

10.1001/jama.1992.03480010072027

Lipton RB, 1993, Migraine in the United States: a review of epidemiology and health care use, Neurology, 43, S6

Stewart WF, 1994, Migraine prevalence: a review of population‐based studies, Neurology, 44, S17

Silberstein SD, 1992, The role of sex hormones in headache, Neurology, 42, S37

Aube M, 1999, Migraine in pregnancy, Neurology, 53, S26

National Center for Chronic Disease Prevention and Health Promotion, Diabetes, Chronic disease prevention

Cowie CC, 1995, National Diabetes Data Group. Diabetes in America, 85

Kenny SJ, 1995, National Diabetes Data Group. Diabetes in America, 47

Wishner KL, 1996, Diabetes mellitus: its impact on women, Int J Fertil, 41, 177

Fishbein H, 1995, National Diabetes Data Group. Diabetes in America, 283

10.1093/oxfordjournals.aje.a113577

10.1002/(SICI)1096-9136(199707)14:7<571::AID-DIA384>3.0.CO;2-Y

10.1016/0165-0327(93)90026-G

Kornstein SG, 1997, Gender differences in depression: implications for treatment, J Clin Psychiatry, 58, 12

10.1002/depr.3050030103

10.1037/0033-2909.101.2.259

10.1176/ajp.145.1.41

10.1097/00005053-199003000-00008

Kornstein SG, 1996, Gender differences in presentation of chronic major depression, Psychopharmacol Bull, 31, 711

10.1176/ajp.151.4.500

10.1016/S0197-0070(81)80087-3

Wagner KD, 1994, Norplant‐associated major depression and panic disorder, J Clin Psychiatry, 55, 478

10.1111/j.1471-0528.1986.tb07868.x

10.1192/bjp.113.495.183

Hamilton JA, 1996, Psychopharmacology and women: sex, gender, and hormones, 241

Preskorn SH, 1985, Plasma levels of amitriptyline: effects of age and sex, J Clin Psychiatry, 46, 276

10.1002/cpt1974164639

Ziegler VE, 1977, Tricyclic plasma levels. Effect of age, race, sex, and smoking, JAMA, 238, 2167, 10.1001/jama.1977.03280210059023

10.2165/00003088-199019030-00007

10.1038/clpt.1987.132

10.1097/00004850-199112002-00004

10.1038/clpt.1984.114

10.1002/cpt1975175555

10.1016/0009-8981(87)90161-6

10.1176/ajp.150.10.1541

10.1192/bjp.162.2.175

10.1097/00005053-197408000-00006

10.1001/archpsyc.1977.01770140087010

10.1001/archpsyc.1972.01750210042009

10.1016/0165-1781(86)90063-6

Dawkins K, 1991, Gender differences in pharmacokinetics and pharmacodynamics of psychotropics: focus on women, Psychopharmacol Bull, 27, 417

10.1016/0006-3223(90)90484-J

Stewart DE, 1998, Are there special considerations in the prescription of serotonin reuptake inhibitors for women?, Can J Psychiatry, 43, 900, 10.1177/070674379804300903

Epilepsy Foundation.Epilepsy facts & figures. Available from:http:www.efa.orgeducationfacts.html.

Epilepsy Foundation Society for Women's Health Research.Scientific Advisory Meeting VIII: Annual Update on Women's Health Research: Discoveries and Implications. Available from:http:www.womens‐health.orgresstatepile.htm.

10.1111/j.1528-1157.1985.tb05723.x

10.1111/j.1528-1157.1991.tb05889.x

10.1212/WNL.51.5_Suppl_4.S21

10.1212/WNL.51.4.949

10.1111/j.1528-1157.1997.tb04537.x

10.1001/archinte.158.13.1405

Boggess KA, 1990, Influence of the menstrual cycle on systemic diseases, Obstet Gynecol Clin North Am, 17, 321, 10.1016/S0889-8545(21)00217-5

10.1136/thx.54.3.265

10.1055/s-2007-1016390

10.1111/j.1528-1157.1993.tb02097.x

10.1097/00001703-199404000-00002

Reid RL, 1992, Use of GnRH agonists for menstrual cycle‐related disorders, J Soc Obstet Gynaecol Can, 14, 59

10.1016/S0015-0282(97)81928-0

Bauer J, 1992, The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients, J Neurol, 239, 284, 10.1007/BF00810354

McEvoy GK, 1999, AHFS drug information 99, 932

Canadian Pharmaceutical Association, 1999, Compendium of pharmaceuticals and specialties

10.1001/archneurpsyc.1931.02230110151009

10.1016/0007-0971(81)90010-3

10.1136/thx.39.11.833

Barkman RP, 1981, Sudden death in asthma [letter], Med J Aust, 1, 316, 10.5694/j.1326-5377.1981.tb135596.x

10.1001/archinte.1996.00440150091010

Aoyama Y, 1965, Relation between bronchial asthma and the menstrual cycle, Jpn J Allergy, 14, 583

10.1016/0091-6749(87)90240-5

10.1016/0091-6749(86)90328-3

Eliasson O, 1984, Recurrent respiratory failure in premenstrual asthma, Conn Med, 48, 777

Koullapis EN, 1980, The concentration of 13, 13‐dihydro‐15‐Oxo‐prostaglandin F2alpha in peripheral venous plasma throughout the normal ovarian and menstrual cycle, Acta Endocrinol, 93, 123

10.3109/02770907009104290

10.1111/j.1476-5381.1983.tb09409.x

10.1111/j.1365-2044.1987.tb05275.x

Juniper EF, 1987, Airway responsiveness to methacholine during the natural menstrual cycle and effect of oral contraceptives, Am Rev Respir Dis, 135, 1039

10.1016/S0140-6736(88)92837-1

10.1002/j.1875-9114.1997.tb03703.x

10.1592/phco.19.6.374.31050

10.1378/chest.111.4.847

10.1164/ajrccm.155.4.9105066

10.1136/thx.52.7.608

10.1210/jcem-57-6-1193

10.1016/0008-8749(92)90269-U

10.1161/01.CIR.92.1.5

10.1592/phco.19.18.1426.30902

10.1016/S0091-6749(99)70327-1

Johnston RU, 1995, Menstrual “asthma”—therapy?, [letter] Fertil Steril, 63, 1131, 10.1016/S0015-0282(16)57563-3

Gorrell GJ, 1985, Relief of asthma with danazol [letter], Can Med Assoc J, 132, 100

Pride SM, 1984, Relief of asthma in two patients receiving danazol for endometriosis, Can Med Assoc J, 131, 763

Blumenfeld Z, 1994, Menstrual asthma: use of a gonadotropin‐releasing hormone analogue for the treatment of cyclic aggravation of bronchial asthma, Fertil Steril, 62, 197, 10.1016/S0015-0282(16)56842-3

10.1016/0002-9343(83)90789-1

10.1136/ard.42.4.425

10.1136/ard.52.1.65

10.1016/S0140-6736(83)92378-4

10.1016/S0140-6736(78)90209-X

10.1016/S0140-6736(83)92413-3

10.1016/0895-4356(90)90023-I

10.1097/00000441-195107000-00006

Nattero L, 1982, Menstrual headache, Adv Neurol, 33, 215

10.1097/00003081-198706000-00022

10.1007/BF00857528

10.1212/WNL.22.4.355

10.1212/WNL.41.6.786

10.1136/jnnp.46.11.1044

10.1111/j.1468-2982.1999.1901016.x

10.1056/NEJM198403153101114

Cramer HI, 1942, The influence of menstruation on carbohydrate tolerance in diabetes mellitus, Can Med Assoc J, 47, 51

10.1136/bmj.2.6080.177

10.2337/diacare.15.2.213

10.1111/j.1464-5491.1993.tb00096.x

10.1136/bmj.2.4895.1022

10.1016/S0015-0282(16)60120-6

10.1136/bmj.2.5604.528

Roy SK, 1971, Changes in oral glucose tolerance during normal menstrual cycle, J Ind Med Assoc, 57, 201

Spellacy WN, 1967, Menstrual cycle carbohydrate metabolism, Am J Obstet Gynecol, 99, 382, 10.1016/S0002-9378(16)34546-X

10.1111/j.1471-0528.1975.tb02216.x

10.1016/S0002-9378(87)80365-4

10.1016/0022-4731(75)90333-7

10.1001/archinte.1994.00420160108015

10.1016/0165-0327(93)90033-G

10.1176/ajp.139.4.475

10.3109/01674829209009200

10.1089/jwh.1992.1.109

Gowers BR, 1995, Epilepsy and other chronic convulsive diseases—their causes, symptoms, and treatment

10.1016/0920-1211(89)90037-5

10.1111/j.1528-1157.1997.tb01197.x

10.1111/j.1600-0404.1976.tb04363.x

10.1111/j.1479-828X.1993.tb02067.x

10.3810/pgm.1997.07.253

10.1136/jnnp.49.1.47

10.1212/WNL.34.7.959

10.1111/j.1528-1157.1988.tb04412.x

10.1212/WNL.34.9.1255

10.1055/s-2008-1041384

10.1212/WNL.38.3.432